~~<i id='14B81FE9F5'><strike id='14B81FE9F5'><tt id='14B81FE9F5'><pre id='14B81FE9F5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：entertainment 2025-08-12 09:12:47 - browse：1

Photo illustration of a single pill on a large white field – opinion coverage from STAT — Adobe

This time last year, members of Congress were working around the clock to draft and pass the Inflation Reduction Act.

One of their goals was to address government spending on health care. But they specifically didn’t want to discourage research into rare disease treatments, so they exempted some of these so-called orphan drugs from the law.

Unfortunately, the exemptions aren’t working as intended. Unless Congress acts, the IRA threatens to unravel one of America’s greatest medical and public policy success stories: the explosion of new treatments for patients living with rare diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Judge sides with young activists in first

hotspot

focus

leisure time

hotspot

leisure time

knowledge

Rakus,aSumatranorangutan,usedthejuiceandleavesofamedicinalplanttotreatawoundonhisface.CourtesyArmasW

WSS

Getting Alzheimer's drug Leqembi to patients can be a challenge

YouTube cracks down on misinformation on cancer treatment

Dozens dead from Maui wildfires: What we know about the victims

Q&A: Jennifer Adair on making gene therapy available globally

Melinda French Gates resigns from Gates Foundation

Cholera vaccine supply gets boost as demand surges globally

hotspot

explore

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Jerome Adams on the need for new antivirals for Covid

Getting Alzheimer's drug Leqembi to patients can be a challenge

In age of alternative facts, a scholarly course on calling out crap

Dozens dead from Maui wildfires: What we know about the victims

Jerome Adams on the need for new antivirals for Covid

Megan Rapinoe shares emotional post following US Women's World Cup exit

How to save PrEP access — and even expand it

Maui wildfire now ranks as the fifth

focus

Exact Sciences stock tumbles despite strong cancer detection sales

Treatments for cramps don't cut it. Why aren't there better options?

Illumina slashes 2023 revenue projections yet again

Health care needs a new profession: neuroimaging counseling

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

FTC falls short on scrutinizing hospital mergers, study says

leisure time

hotspot

leisure time

knowledge